Bank of New York Mellon’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $943K | Sell |
137,000
-6,588
| -5% | -$45.3K | ﹤0.01% | 3142 |
|
|
2025
Q1 | $414K | Buy |
143,588
+1,715
| +1% | +$4.94K | ﹤0.01% | 3527 |
|
|
2024
Q4 | $667K | Buy |
141,873
+3,126
| +2% | +$14.7K | ﹤0.01% | 3354 |
|
|
2024
Q3 | $495K | Sell |
138,747
-47,980
| -26% | -$171K | ﹤0.01% | 3515 |
|
|
2024
Q2 | $1.16M | Buy |
+186,727
| New | +$1.16M | ﹤0.01% | 3108 |
|
|
2024
Q1 | – | Sell |
-19,831
| Closed | -$134K | – | 4206 |
|
|
2023
Q4 | $134K | Sell |
19,831
-41,359
| -68% | -$279K | ﹤0.01% | 4030 |
|
|
2023
Q3 | $272K | Sell |
61,190
-1,132
| -2% | -$5.03K | ﹤0.01% | 3847 |
|
|
2023
Q2 | $206K | Sell |
62,322
-149,879
| -71% | -$495K | ﹤0.01% | 3963 |
|
|
2023
Q1 | $605K | Buy |
212,201
+14,345
| +7% | +$40.9K | ﹤0.01% | 3386 |
|
|
2022
Q4 | $1.44M | Buy |
197,856
+65,383
| +49% | +$476K | ﹤0.01% | 3019 |
|
|
2022
Q3 | $1.07M | Buy |
132,473
+28,053
| +27% | +$227K | ﹤0.01% | 3173 |
|
|
2022
Q2 | $512K | Buy |
104,420
+3,781
| +4% | +$18.5K | ﹤0.01% | 3565 |
|
|
2022
Q1 | $2.38M | Sell |
100,639
-31
| -0% | -$733 | ﹤0.01% | 2831 |
|
|
2021
Q4 | $1.78M | Buy |
100,670
+5,639
| +6% | +$99.8K | ﹤0.01% | 3062 |
|
|
2021
Q3 | $2.68M | Buy |
95,031
+31,059
| +49% | +$876K | ﹤0.01% | 2820 |
|
|
2021
Q2 | $670K | Buy |
63,972
+21,725
| +51% | +$228K | ﹤0.01% | 3629 |
|
|
2021
Q1 | $497K | Sell |
42,247
-765
| -2% | -$9K | ﹤0.01% | 3689 |
|
|
2020
Q4 | $504K | Buy |
43,012
+6,457
| +18% | +$75.7K | ﹤0.01% | 3612 |
|
|
2020
Q3 | $291K | Buy |
36,555
+4,641
| +15% | +$36.9K | ﹤0.01% | 3730 |
|
|
2020
Q2 | $583K | Sell |
31,914
-1,389
| -4% | -$25.4K | ﹤0.01% | 3400 |
|
|
2020
Q1 | $398K | Buy |
+33,303
| New | +$398K | ﹤0.01% | 3481 |
|